Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Human Gene Therapy|October 21, 2016
Genetically Engineered Macrophages: A Potential Platform for Cancer ImmunotherapyKara W Moyes, Nicole A P Lieberman, Shannon A Kreuser, et al.Journal for Immunotherapy of Cancer|October 30, 2020
Human macrophages engineered to secrete a bispecific T cell engager support antigen-dependent T cell responses to glioblastomaJennifer L Gardell, Lisa R Matsumoto, Harrison Chinn, et al.Cancer Gene Therapy|June 9, 2023
Production of an interleukin-10 blocking antibody by genetically engineered macrophages increases cancer cell death in human gastrointestinal tumor slice culturesKevin P Labadie, Shannon A Kreuser, Katherine J Brempelis, et al.Advanced Healthcare Materials|December 10, 2021
Arming Immune Cell Therapeutics with Polymeric ProdrugsCiana L López, Katherine J Brempelis, James F Matthaei, et al.Oncoimmunology|November 1, 2018
Effects of tumor grade and dexamethasone on myeloid cells in patients with gliomaKara W Moyes, Amira Davis, Virginia Hoglund, et al.Neuro-Oncology|December 4, 2019
Anti-PD-L1 antibody direct activation of macrophages contributes to a radiation-induced abscopal response in glioblastomaChibawanye I Ene, Shannon A Kreuser, Miyeon Jung, et al.Journal for Immunotherapy of Cancer|October 29, 2020
Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responsesKatherine J Brempelis, Courtney M Cowan, Shannon A Kreuser, et al.Pageof 1